Company overview
Gilson provides high-quality materials testing equipment for aggregates, asphalt, concrete, and geotechnical applications used in construction and related industries. Their product line includes concrete testing equipment for compliance, strength, and consistency, as well as aggregate testing tools to evaluate physical characteristics for asphalt and concrete mixes. They offer innovative solutions like the Gilson Guardian cloud-based platform for real-time data tracking, testing, and reporting of concrete specimens.
Gilson is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include materials testing equipment, concrete testing, aggregate testing, asphalt testing, gilson guardian.
Products and technologies associated with Gilson include Equipment — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.globalgilson.com
- Markets served
- United States & Americas
- Keywords
- materials testing equipment, concrete testing, aggregate testing, asphalt testing, gilson guardian
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What types of materials testing equipment does Gilson offer?
- Gilson offers equipment for testing aggregates, asphalt, concrete, and geotechnical materials, including tools for particle size analysis, sample dividing, compliance, strength, and consistency testing.
- What is Gilson Guardian and how does it work?
- Gilson Guardian is a secure cloud-based platform with a mobile app for field data recording, software integrating with compression machines, and cloud sharing for real-time tracking and reporting of concrete specimens.
- What industries does Gilson serve with their equipment?
- Gilson serves the construction industry, including mining, highway construction, aggregate labs, and applications in asphalt, concrete, and geotechnical testing.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
